Emerson Electric Co.
Surendralal Lanca Karsanbhai (President & CEO) reports EMR insider transactions
AI-generated summary
President & CEO, Director Surendralal Lanca Karsanbhai received 187,936 shares as a grant in two transactions. Surendralal Lanca Karsanbhai also had 70,060 shares disposed of for tax withholding at an average price of $167.78, valued at $11,754,378.52. After these transactions, Surendralal Lanca Karsanbhai directly held 301,174.4016 shares.
Key facts
- Insider
- Surendralal Lanca Karsanbhai · President & CEO, Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | A · grantFootnotes F1, F2 | +140,886 | — | — | 324,184.4016 | Direct |
| Nov 2, 2026 | F · tax withholdingFootnotes F3, F4 | −62,061 | $167.95 | $10,423,144.95 | 262,123.4016 | Direct |
| Nov 2, 2026 | A · grantFootnotes F5, F6 | +47,050 | — | — | 309,173.4016 | Direct |
| Nov 3, 2026 | F · tax withholdingFootnotes F7, F8 | −7,999 | $166.43 | $1,331,233.58 | 301,174.4016 | Direct |
Footnotes
- F1 Acquisition of shares pursuant to Rule 16b-3 upon payout of 140,886 earned units under a performance share award under a shareholder-approved benefit plan. The payout was based on the level of achievement of financial targets for the performance period ended September 30, 2026.
- F2 Price is not applicable to the acquisition described in Note 1.
- F3 Shares withheld for required minimum taxes upon vesting of units under a performance share award described in Note 1.
- F4 Fair market value on date of withholding described in Note 3.
- F5 Grant to Reporting Person of 47,050 restricted stock units under shareholder approved benefit plan pursuance to Rule 16b-3(d).
- F6 Price is not applicable to acquisitions resulting from grants of restricted stock units.
- F7 Shares withheld for required minimum taxes upon vesting of previously reported stock grant under shareholder approved benefit plan exempt pursuant to Rule 16b-3.
- F8 Fair market value on date of withholding described in Note 7.
More EMR filings
- 4
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.